Insmed INSM Return on invested capital

Return on invested capital at other companies

Solid Biosciences Inc.SLDB

-191.5%+205pp

ANI PharmaceuticalsANIP

17.2%+15.9pp

Regeneron PharmaceuticalsREGN

10.3%-1.5pp

SavaraSVRA

-82.5%+8.5pp

ArriVent BioPharma, Inc.AVBP

-75.6%-28.0pp

Theravance BiopharmaTBPH

1.5%+0.8pp

FAQ

What is Insmed's return on invested capital?

Insmed (INSM) reported return on invested capital of -149.4% in Q1 2026.

How has Insmed's return on invested capital changed year-over-year?

Insmed's return on invested capital increased by 24.7% year-over-year, from -198.3% to -149.4%.

What is the long-term trend for Insmed's return on invested capital?

Over 5 years (2020 to 2025), Insmed's return on invested capital has grown at a -2.3% compound annual growth rate (CAGR), from -165% to -146.6%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.